Product Code: ETC9402468 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Edaravone Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Edaravone Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Edaravone Market - Industry Life Cycle |
3.4 South Korea Edaravone Market - Porter's Five Forces |
3.5 South Korea Edaravone Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 South Korea Edaravone Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.7 South Korea Edaravone Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Korea Edaravone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurodegenerative diseases in South Korea |
4.2.2 Growing awareness about the effectiveness of edaravone in treating conditions like ALS |
4.2.3 Favorable government initiatives and policies supporting healthcare infrastructure development |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval process for new drugs in South Korea |
4.3.2 High cost associated with edaravone treatment |
4.3.3 Limited availability of skilled healthcare professionals specializing in neurology |
5 South Korea Edaravone Market Trends |
6 South Korea Edaravone Market, By Types |
6.1 South Korea Edaravone Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 South Korea Edaravone Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 South Korea Edaravone Market Revenues & Volume, By Oral, 2021- 2031F |
6.1.4 South Korea Edaravone Market Revenues & Volume, By Injection, 2021- 2031F |
6.2 South Korea Edaravone Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 South Korea Edaravone Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 South Korea Edaravone Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 South Korea Edaravone Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.5 South Korea Edaravone Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.3 South Korea Edaravone Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 South Korea Edaravone Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 South Korea Edaravone Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 South Korea Edaravone Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 South Korea Edaravone Market Import-Export Trade Statistics |
7.1 South Korea Edaravone Market Export to Major Countries |
7.2 South Korea Edaravone Market Imports from Major Countries |
8 South Korea Edaravone Market Key Performance Indicators |
8.1 Patient adoption rate of edaravone treatment |
8.2 Number of clinical trials or studies involving edaravone in South Korea |
8.3 Rate of reimbursement for edaravone treatment by health insurance providers |
9 South Korea Edaravone Market - Opportunity Assessment |
9.1 South Korea Edaravone Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 South Korea Edaravone Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.3 South Korea Edaravone Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Korea Edaravone Market - Competitive Landscape |
10.1 South Korea Edaravone Market Revenue Share, By Companies, 2024 |
10.2 South Korea Edaravone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |